OSR Health (OSRHW) Return on Capital Employed (2023 - 2026)
OSR Health (OSRHW) posted Return on Capital Employed of 12.41% for Q1 2026, down 6.31% sequentially from 11.67% in Q4 2025, and down 539.0% YoY from 2.83% in Q1 2025.
OSR Health (OSRHW) Return on Capital Employed (2023 - 2026) Analysis & Trends
OSR Health has reported Return on Capital Employed for 4 years, with the latest figure at 12.41% in Q1 2026.
- Quarterly Return on Capital Employed fell 539.0% year-over-year to 12.41% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 12.41% (down 539.0% YoY) and the FY2025 annual result came in at 11.75%, down 34.0% from the prior year.
- Return on Capital Employed fell to 12.41% in Q1 2026 per OSRHW's latest filing, from 11.67% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 2.48% in Q4 2023 and troughed at 57.35% in Q3 2024.
- A 4-year average of 10.88% and a median of 8.12% in 2025 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2024 and 2025: Return on Capital Employed tumbled 5857 bps in 2024, then jumped 4920 bps in 2025.
- Over 4 years, Return on Capital Employed stood at 2.48% in 2023, then tumbled by 597 bps to 12.35% in 2024, then gained by 6 bps to 11.67% in 2025, then dropped by 6 bps to 12.41% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 12.41%, 11.67%, and 8.15% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn | 20.76% |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn | 10.74% |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn | -38.20% |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn | 13.68% |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 26.09% |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn | -6.85% |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 7.88% |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn | -50.93% |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 | -10.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.41% |
| Dec 31, 2025 | -11.67% |
| Sep 30, 2025 | -8.15% |
| Jun 30, 2025 | -8.12% |
| Mar 31, 2025 | -7.02% |
| Dec 31, 2024 | -12.35% |
| Sep 30, 2024 | -57.35% |
| Jun 30, 2024 | -23.03% |
| Mar 31, 2024 | -6.26% |
| Dec 31, 2023 | 2.48% |
| Sep 30, 2023 | 1.22% |
| Jun 30, 2023 | 0.90% |
| Mar 31, 2023 | 0.29% |